Erratum: Association of Gensini Score with 30-Day Mortality Rates in Acute Coronary Syndrome Patients in China - Scorecard - MDSpire

Erratum: Association of Gensini Score with 30-Day Mortality Rates in Acute Coronary Syndrome Patients in China

  • By

  • Yi Zhang

  • Rong Luo

  • Xiaochen Sun

  • Jiasheng Cai

  • Mohammed Ahmed Al-Kaif

  • Zhonghua Wang

  • Chunlei Li

  • Chuntao Wu

  • Zilong Wang

  • Zhuqin Li

  • Haibo Liu

  • April 15, 2026

  • 0 min

Share

Clinical Scorecard: Erratum: Association of Gensini Score with 30-Day Mortality Rates in Acute Coronary Syndrome Patients in China

At a Glance

CategoryDetail
ConditionAcute Coronary Syndrome
Key MechanismsGensini Score as a predictor of mortality
Target PopulationPatients with Acute Coronary Syndrome in China
Care SettingCardiovascular care

Key Highlights

  • Correction of author's name in the original article
  • Focus on Gensini Score's association with mortality
  • Study conducted in a Chinese population

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Acute Coronary Syndrome patients

          Gensini Score may inform risk stratification

          Clinical Best Practices

            References

            Original Source(s)

            Erratum: Association of Gensini Score with 30-Day Mortality Rates in Acute Coronary Syndrome Patients in China

            • by Yi Zhang, Rong Luo, Xiaochen Sun, Jiasheng Cai, Mohammed Ahmed Al-Kaif, Zhonghua Wang, Chunlei Li, Chuntao Wu, Zilong Wang, Zhuqin Li, Haibo Liu

            • April 15, 2026

            Related Content

            Relationship of Initial Blood Glucose Levels to Atypical Angina in Individuals with Coronary Artery Disease

            Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

            Assessment of Safety and Efficacy of Varying Durations of Dual Antiplatelet Therapy with Aspirin and Ticagrelor Following Successful Percutaneous Coronary Intervention in Diabetic Patients with Acute Coronary Syndrome